Research
First evidence from a Chinese population supports review of long-term blood monitoring for local clozapine use
The Brief
- An international team led by HKUMed's Department of Psychiatry completed a long-term population-based study on clozapine use in a Chinese population.
- The study concerns people with treatment-resistant schizophrenia and the blood monitoring used during clozapine treatment.
- The findings are presented as supporting a review of long-term blood monitoring requirements for local clozapine use.
Why it matters
Clozapine requires regular blood monitoring for a rare but serious side effect, so evidence from a large real-world population bears directly on how often patients are tested and on the cost and burden of that monitoring.
Who’s affected
- psychiatrists and clinicians prescribing clozapine
- patients with treatment-resistant schizophrenia
- health policymakers responsible for clozapine monitoring rules
- #clozapine
- #schizophrenia
- #blood monitoring
- #psychiatry
- #drug safety
An international research team led by the Department of Psychiatry, School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has completed a long-term population-based research study to improve care for people with treatment-resistant…